Stocks rallied in the afternoon after the January Consumer Price Index showed softer-than-expected inflation, raising hopes for Federal Reserve interest rate cuts. The CPI rose 0.2%, with the annual rate at 2.4%, leading the market to anticipate rate cuts as early as June. Treasuries saw a rally as yields dropped. Amphastar Pharmaceuticals (AMPH) saw a significant move, with shares up 8.2% year-to-date but still 11.3% below their 52-week high. Analysts had recently cut price targets and noted challenges in the company’s product portfolio, impacting sales outlook. Investors are advised to consider the company’s trajectory carefully.

Read more at StockStory Media: Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know